- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about HRTX
Recent news which mentions HRTX
Why Verona Pharma Is Trading Higher By Around 84%, Here Are 85 Stocks Moving In Tuesday's Mid-Day Session
August 09, 2022
From Benzinga
From Benzinga
7 Biotech Stocks to Buy for Q3
July 18, 2022
From InvestorPlace
Stocks That Hit 52-Week Lows On Monday
June 06, 2022
From Benzinga
From Benzinga
From Motley Fool
80 Biggest Movers From Yesterday
March 02, 2022
From Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
March 01, 2022
From Benzinga
44 Stocks Moving In Tuesday's Mid-Day Session
March 01, 2022
From Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
March 01, 2022
From Benzinga
From Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
February 28, 2022
From Benzinga
Earnings Scheduled For February 28, 2022
February 28, 2022
From Benzinga
The Week Ahead In Biotech (Feb. 27-March 5): Earnings, Multiple Regulatory Decisions Take The Spotlight
February 27, 2022
From Benzinga
Why Heron Therapeutics Shares Rose Nearly 15% This Week
December 09, 2021
Tickers
HRTX
From Motley Fool
Mid-Afternoon Market Update: Nasdaq Falls Over 1%; Reata Pharmaceuticals Shares Plummet
December 09, 2021
From Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
December 09, 2021
From Benzinga
2 Short-Squeeze Candidates That Could Go Parabolic Soon
December 09, 2021
From Motley Fool
The Daily Biotech Pulse: Cerus Climbs On Earnings, Horizon CFO To Retire, Teva Prices Upsized Sustainability-Linked Senior Note Offering
November 03, 2021
From Benzinga
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
October 31, 2021
From Benzinga
From Motley Fool
From Benzinga
The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal
October 06, 2021
From Benzinga
Can These Former Biotech Growth Stocks Regain Their Form?
September 29, 2021
From Motley Fool
Heron Therapeutics's Return On Capital Employed Overview
September 21, 2021
Tickers
HRTX
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.